Core Insights - New Zhi Bio is one of the earliest companies in China focused on the research, production, and sales of life science instruments, with over 20 product lines and more than 200 product models covering three main areas: biological sample processing, molecular biology and drug research, and laboratory automation [2] - The company went public on the Beijing Stock Exchange in 2022, marking a significant milestone in its development, and has since expanded its product lines and transformed from a laboratory equipment supplier to a comprehensive service provider covering the entire process from experimentation to mass production [2][6] - New Zhi Bio is leveraging capital to accelerate industry integration, having acquired 55% of Ningbo Afus Constant Temperature Company to enhance its capabilities in industrial temperature control solutions [3] Product Development and Market Strategy - The company has continuously iterated on traditional products while expanding new product lines, including industrial-grade products in ultrasonic processing and customized models for cross-industry applications, maintaining a stable customized business ratio of over 20% [2] - New Zhi Bio emphasizes the importance of strategic flexibility and resource allocation to capture potential opportunities beyond traditional academic research settings [3] - The company is focusing on high-end instruments and global expansion, with plans to establish a localized service network for its foreign trade business, moving from reliance on foreign distributors to a direct service model [5][7] Capital Market and Industry Trends - The Beijing Stock Exchange has played a crucial role in supporting innovative small and medium-sized enterprises, enhancing brand influence and facilitating comprehensive improvements in product development, market expansion, and organizational capabilities for New Zhi Bio [6][9] - The domestic scientific instrument industry is experiencing a historic development window, with significant investments in technology research and talent, allowing some products to approach or exceed international advanced levels [7] - New Zhi Bio aims to become a "research supermarket" and a provider of comprehensive solutions, leveraging the opportunities presented by the Beijing Stock Exchange to collaborate with leading companies in niche markets [9]
2025北交所万里行｜新芝生物：攻坚中高端市场，加速全球化布局